Featured Research

from universities, journals, and other organizations

AAAS Urges President Bush To Fund Stem-Cell Research

Date:
March 8, 2001
Source:
American Association For The Advancement Of Science
Summary:
The American Association for the Advancement of Science (AAAS) sent a letter to President George W. Bush expressing its strong support for federal funding of research using human stem cells from embryonic, fetal and adult sources. "It would be tragic," the letter states, "to squander this opportunity to pursue work that can potentially help millions of Americans in need."

Washington D.C. (6 March 2001) -- The American Association for the Advancement of Science (AAAS) sent a letter to President George W. Bush expressing its strong support for federal funding of research using human stem cells from embryonic, fetal and adult sources. "It would be tragic," the letter states, "to squander this opportunity to pursue work that can potentially help millions of Americans in need."

According to the letter, the discovery of stem cells, capable of giving rise to virtually any tissue type, could be the most significant scientific and medical breakthrough in the past decade. The result of such research could lead to treatments and/or cures for some of America's most degenerative illnesses, including Alzheimer's disease, diabetes, spinal cord injury, and heart disease. In addition, the study of stem cells could contribute to the understanding of birth defects and the development of new drugs targeted at specific diseases.

The letter, which was signed by Mary L. Good, chair of the AAAS Board, Peter H. Raven, president of AAAS, and Floyd E. Bloom, president-elect of AAAS, offers to assist the administration in its review of current federal policy regarding stem-cell research. The AAAS officers expressed their wish that government policy will not foreclose the hope that the many sufferers of disease and disability have vested in stem-cell research.

The letter acknowledges that there is a common misconception that the use of adult stem cells-as opposed to embryonic and fetal stem cells-will be sufficient for research. The AAAS notes that, based on current knowledge, many in the scientific community doubt that adult stem cells will be as effective as other stem cells in treating diseases.

In addition to the letter, a detailed AAAS report on the subject of stem-cell research was sent to President Bush. Based on many months of study by scientists, ethicists, and theologians, the November 1999 report recommends that "federal funding for stem cell research is necessary in order to promote investment in this promising line of research, to encourage sound public policy, and to foster public confidence in the conduct of such research." The report also addresses ethical concerns raised by the use of embryonic and fetal stem cells and concludes that it is possible to conduct embryonic stem-cell research in a fully ethical manner.

According to the report, the case for public funding is made even stronger by the amount of stem-cell research taking place in the private sector without public oversight. Public funding, the reports states, would help to ensure that the research is closely monitored and meets ethical standards.

Founded in 1848, AAAS is the world's largest federation of scientists with more than 138,000 individual members and 273 affiliated societies. The Association publishes the weekly, peer-reviewed journal Science and administers EurekAlert! (http://www.eurekalert.org), the online news service featuring the latest discoveries in science and technology.

Editor's Note: The stem-cell research report can be accessed athttp://www.aaas.org/spp/dspp/sfrl/projects/stem/main.htm


Story Source:

The above story is based on materials provided by American Association For The Advancement Of Science. Note: Materials may be edited for content and length.


Cite This Page:

American Association For The Advancement Of Science. "AAAS Urges President Bush To Fund Stem-Cell Research." ScienceDaily. ScienceDaily, 8 March 2001. <www.sciencedaily.com/releases/2001/03/010308071407.htm>.
American Association For The Advancement Of Science. (2001, March 8). AAAS Urges President Bush To Fund Stem-Cell Research. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2001/03/010308071407.htm
American Association For The Advancement Of Science. "AAAS Urges President Bush To Fund Stem-Cell Research." ScienceDaily. www.sciencedaily.com/releases/2001/03/010308071407.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins